In conclusion, we demonstrated that HNSCC patients exhibit a systemic immune suppression caused by the malignant condition, which manifested in a compromised CD4 cell function and increase in the fraction of immune suppressive Tregs and effector CD4 cells. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.